ICU Medical, Inc.
ICUI
$125.85
-$2.93-2.28%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 540.70M | 536.99M | 548.87M | 604.70M | 629.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 540.70M | 536.99M | 548.87M | 604.70M | 629.81M |
| Cost of Revenue | 337.72M | 336.11M | 340.80M | 394.59M | 402.55M |
| Gross Profit | 202.99M | 200.88M | 208.06M | 210.11M | 227.26M |
| SG&A Expenses | 155.81M | 152.77M | 159.39M | 157.23M | 158.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 514.62M | 510.13M | 522.06M | 575.12M | 583.75M |
| Operating Income | 26.09M | 26.86M | 26.81M | 29.59M | 46.05M |
| Income Before Tax | -18.39M | -4.05M | 36.52M | -10.91M | 8.22M |
| Income Tax Expenses | -2.65M | -658.00K | 1.18M | 4.57M | 32.05M |
| Earnings from Continuing Operations | -15.73M | -3.40M | 35.34M | -15.48M | -23.83M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.73M | -3.40M | 35.34M | -15.48M | -23.83M |
| EBIT | 26.09M | 26.86M | 26.81M | 29.59M | 46.05M |
| EBITDA | 76.92M | 77.66M | 76.47M | 79.03M | 99.05M |
| EPS Basic | -0.64 | -0.14 | 1.43 | -0.63 | -0.97 |
| Normalized Basic EPS | 0.12 | 0.19 | 0.28 | 0.15 | 0.46 |
| EPS Diluted | -0.64 | -0.14 | 1.43 | -0.63 | -0.98 |
| Normalized Diluted EPS | 0.12 | 0.19 | 0.28 | 0.15 | 0.46 |
| Average Basic Shares Outstanding | 24.69M | 24.69M | 24.65M | 24.54M | 24.49M |
| Average Diluted Shares Outstanding | 24.69M | 24.69M | 24.71M | 24.54M | 24.49M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |